ConductScience.org, home

Paper16639716

Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions.

Rodgers T and 1 other. J Pharm Sci, 2006. Cited by 781 papers, by iCite.

Cite this record

ConductScience Library. Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. Papers, record 16639716. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16639716

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions.
PubMed
Journal
J Pharm Sci
PubMed
Year
2006
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
781
iCite
Relative citation ratio, by iCite
27.5
iCite
Revised in PubMed
2023-01-20
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rodgers TTrudy
2Rowland MMalcolm

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Models, BiologicalMajor topic
PharmacokineticsMajor topic
Animals
Blood Proteins
Body Fluid Compartments
Computer Simulation
Erythrocytes
Octanols
Phospholipids
Predictive Value of Tests
Quantitative Structure-Activity Relationship
Rats
Tissue Distribution
Water

Source PubMed

Download CSV of topics

Cited by433

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 781 citations.

PMIDTitleJournalYearIn PapersSource
42942743PBPK Modeling of CES1-Activated Prodrugs Across Different Age Groups: Simultaneous Prodrug-Metabolite Prediction for Oseltamivir, Enalapril, and Cilazapril.Pharmaceutics2026https://conductscience.org/library/papers/42942743PubMed
42872351Mechanistic Prediction of Maternal, Fetal, and Amniotic Fluid Betamethasone Concentrations to Support Dosing Optimization in Pregnancy.J Clin Pharmacol2026https://conductscience.org/library/papers/42872351PubMed
42864476Development of a Mechanistic Distribution Model for Predicting Drug Partitioning into Human Milk.Pharm Res2026https://conductscience.org/library/papers/42864476PubMed
42806801Physiologically Based Pharmacokinetic Modeling to Characterize the Disposition of Topiramate in Children with and without Obesity.J Clin Pharmacol2026https://conductscience.org/library/papers/42806801PubMed
42789173Formalizing method choice: a data-driven selection of mechanistic models for predicting human heart drug partitioning.J Pharmacokinet Pharmacodyn2026https://conductscience.org/library/papers/42789173PubMed
42682186A Practical Alternative to Refine the Estimate of fmCYP3A4 and Evaluate Drug-Drug Interaction Potential for Ziftomenib Using PBPK Modeling to Inform Labeling.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/42682186PubMed
42582297Coproporphyrin I PBPK model in the open systems pharmacology suite enables precise prediction of OATP 1B- mediated drug interactions through calibrated In vivo inhibition constants.Front Pharmacol2026https://conductscience.org/library/papers/42582297PubMed
42571641A Systematic Review of Published Physiologically Based Pharmacokinetic Models for Drug Excretion Into Human Breastmilk: Knowledge Gaps and Opportunities to Optimize Reporting and Modeling Practices.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/42571641PubMed
42528013Sex-Related Differences in Physiologically-Based Biopharmaceutics Modeling.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/42528013PubMed
42418317Predicting First-in-Human Pharmacokinetics: Comparative Evaluation of Standard PBPK, High-Throughput PBPK, and Machine Learning.Mol Pharm2026https://conductscience.org/library/papers/42418317PubMed
42363979PBK modelling of phthalates and their metabolites and the application in next generation risk assessment.Arch Toxicol2026https://conductscience.org/library/papers/42363979PubMed
42353261Complex Distribution Phenomena and Plastic Binding of Test Chemicals in Cell Culture Experiments: Exemplification by Tebufenpyrad.Int J Mol Sci2026https://conductscience.org/library/papers/42353261PubMed
42312170Age-Driven Physiologically Based Pharmacokinetic Modeling of Empagliflozin: Toward Precision Dosing in Youth.ACS Pharmacol Transl Sci2026https://conductscience.org/library/papers/42312170PubMed
42297946Model-informed dose optimization of carvedilol and nebivolol in cirrhotic patients: a pilot randomized clinical study.Sci Rep2026https://conductscience.org/library/papers/42297946PubMed
42251051Prediction variability in physiologically based pharmacokinetic modeling of tissue disposition under deep uncertainty.NPJ Syst Biol Appl2026https://conductscience.org/library/papers/42251051PubMed
42232789Dose optimization of inhaled tigecycline in humans to overcome inherent adverse events and maximize bacterial clearance using a physiologically-based pharmacokinetic modeling approach.Front Tuberc2026https://conductscience.org/library/papers/42232789PubMed
42185666Integrated human toxicokinetics of acetamiprid using urine, blood, and feces data in physiologically-based kinetic modelling for reverse dosimetry.Arch Toxicol2026https://conductscience.org/library/papers/42185666PubMed
42183848Applicability of next-generation risk assessment generic PBK models and their performance within the chemical domain.Arch Toxicol2026https://conductscience.org/library/papers/42183848PubMed
42067648Implementation of growth curves in a generic physiologically based kinetic model with a case study of perfluorooctanesulfonic acid (PFOS) in beef cattle, sheep, and chicken.Arch Toxicol2026https://conductscience.org/library/papers/42067648PubMed
41951999Biodistribution of Cerivastatin, Repaglinide, Glyburide, Rosuvastatin, and Valsartan in Cynomolgus Monkeys and PBPK Analysis.AAPS J2026https://conductscience.org/library/papers/41951999PubMed

See all 433 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16639716

GET https://conductscience.org/api/papers/v1/16639716/cited_by?page=2